Allyson H. Daugherty, PT, CLT, CFM
Vidant Medical CenterAuthored Items
Allyson H. Daugherty, PT, CLT, CFM, Judy Koutlas, RN, MS, OCN, Debra C. Mascarenhas, RN, BSN, BSBA, CBCN
September 23, 2016 | October 2016 Vol 7, No 9
Approximately 42% of breast cancer survivors develop clinically detectable lymphedema within 5 years of treatment. Early intervention and education is crucial to decrease long-term morbidity and improve patient outcomes.
Last modified: June 6, 2018